Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-29 @ 1:52 PM
Study NCT ID:
NCT01540461
Status:
COMPLETED
Last Update Posted:
2014-07-08
First Post:
2012-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
None
Primary Completion Date:
2013-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-11
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-23
First Submit QC Date:
None
Study First Post Date:
2012-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-04
Last Update Post Date:
2014-07-08
Last Update Post Date Type:
ESTIMATED